Loading clinical trials...
Loading clinical trials...
Randomized Double-blind Placebo-controlled Trial of Memantine Hydrochloride for the Treatment of Childhood-onset Epileptic Encephalopathies
Conditions
Interventions
Memantine Hydrochloride 10 mg
Locations
1
Canada
Children Hospital - MUHC
Montreal, Quebec, Canada
Start Date
February 7, 2019
Primary Completion Date
November 8, 2021
Completion Date
February 8, 2022
Last Updated
March 11, 2022
Lead Sponsor
Kenneth Myers, MD
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions